Fundraising Fox

Intervene Inc

Mountain View, US · Founded 2011 · Delaware corporation · 4 known investors

intervene-med.com ↗

InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions. Its technology targets venous disease conditions such as postthrombotic syndrome that current therapies fail to address.

BiotechHealthtechMedical Devices

Founders & leadership

MS
Mel SchatzDirector
TF
Thomas FogartyDirector
FW
Fletcher WilsonExecutive Officer, Director
EN
Evan NgSecretary

Investors · 4

LaunchCapitalBranford · $50K – $150K
RiverVest Venture PartnersSt. Louis · $500K – $3Mvia Jay W. Schmelter · board
Treo Ventures, LlcMinneapolis
Emergent Medical Partners, LLPreportedSan Josevia Thomas J. Fogarty · board

Reported raises · per SEC filings

Form D private placements
▶$1.5MraisedMar 2023 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam BermanDirector
  • Jeffrey ElkinsExecutive Officer, Director
  • Catherine L. MatthesExecutive Officer
  • Ginger GlaserDirector
  • Joe BillerDirector
  • Jay SchmelterDirector
  • Fletcher WilsonDirector
Offering amount
$3M
Amount sold
$1.5M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMar 2023 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ginger GlaserDirector
  • Fletcher WilsonDirector
  • Jay SchmelterDirector
  • Adam BermanDirector
  • Catherine L. MatthesExecutive Officer
  • Joe BillerDirector
  • Jeffrey ElkinsExecutive Officer, Director
Offering amount
$3M
Amount sold
$1.5M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJun 2017 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Evan NgExecutive Officer
  • Thomas FogartyDirector
  • Mel SchatzDirector
  • Jay SchmelterDirector
  • Fletcher WilsonExecutive Officer, Director
Offering amount
$3M
Amount sold
$2.2M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedMar 2015 · 52 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mel SchatzDirector
  • Thomas FogartyDirector
  • Fletcher WilsonExecutive Officer, Director
  • Evan NgExecutive Officer
Offering amount
$7.2M
Amount sold
$5.9M
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.